文献速递生殖医学

基于芯片的DNA甲基化谱分析揭示男性不育患者外周血差异甲基化

Array-based DNA methylation profiling reveals peripheral blood differential methylation in male infertility.
PubMed 文献 · Fertil Steril · 2019-05-15

病例对照研究比较少精不育男性与正常精 fertile 对照的外周血DNA甲基化,发现329个差异甲基化CpG位点,涉及170个基因;深度测序验证了芯片提示的甲基化模式,作者认为外周血DNA甲基化与男性不育存在统计学显著相关,表观基因组血液标志物有望用于筛查男性不育风险。

要点

  • 发现期比较无精/少精不育患者(n=6)与正常精 fertile 对照(n=6),验证期比较少精/弱精不育男性(n=11)与正常精 fertile 对照(n=10)。
  • 全基因组450K芯片发现329个差异甲基化CpG位点,其中245个对应基因,代表170个基因。
  • 深度测序证实了450K芯片提示的甲基化模式,38个基因经文献检索提示与精子发生相关、睾丸富集或在病例与对照间存在甲基化差异。

核心结论

  • 作者报告外周血DNA甲基化与男性不育之间存在统计学显著相关,并提出表观基因组血液标志物有望用于筛查男性不育风险。
  • 研究还鉴定了精子发生与生育力的新候选基因。

研究设计与样本

  • 病例对照研究,在生殖生物学实验室进行。
  • 发现期纳入无精和少精不育患者(n=6)与正常精 fertile 对照(n=6)。
  • 验证期纳入少精/弱精不育男性(n=11)与正常精 fertile 对照(n=10)。

主要发现

  • 发现329个差异甲基化CpG位点,其中245个对应基因,代表170个基因。
  • 深度测序分析证实了450K芯片提示的甲基化模式。
  • 文献检索提示38个基因参与精子发生、睾丸富集或在病例与对照间显示甲基化差异。

关键数值与推荐

  • 使用全基因组甲基化450K BeadChip芯片分析DNA甲基化值,随后对差异甲基化CpG邻近区域进行深度测序甲基化分析。
  • 从所有参与者采集血样,进行DNA分离和甲基化分析。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study peripheral blood DNA differential methylation in oligozoospermic infertile men in comparison with normozoospermic fertile controls. DESIGN: Case-control study. SETTING: Reproductive biology laboratory. PATIENTS(S): Azoospermic and oligozoospermic infertile patients (n = 6) and normozoospermic fertile controls (n = 6) in the discovery phase, and oligo/asthenozoospermic infertile men (n = 11) and normozoospermic fertile controls (n = 10) in the validation phase. INTERVENTION(S): Blood samples drawn from all participants, DNA isolation and methylation analysis. MAIN OUTCOME MEASURE(S): DNA methylation values analyzed using genomewide methylation 450K BeadChip array, followed by deep sequencing of selected regions for methylation analysis in the neighborhood regions of differentially methylated CpGs. RESULT(S): We found 329 differentially methylated CpG spots, out of which 245 referred to the genes, representing 170 genes. Deep-sequencing analysis confirmed the methylation pattern suggested by 450K array. A thorough literature search suggested that 38 genes play roles in spermatogenesis (PDHA2, PARP12, FHIT, RPTOR, GSTM1, GSTM5, MAGI2, BCAN, DDB2, KDM4C, AGPAT3, CAMTA1, CCR6, CUX1, DNAH17, ELMO1, FNDC3B, GNRHR, HDAC4, IRS2, LIF, SMAD3, SOD3, TALDO1, TRIM27, GAA, PAX8, RNF39, HLA-C, HLA-DRB6), are testis enriched (NFATC1, NMNAT3, PIAS2, SRPK2, WDR36, WWP2), or show methylation differences between infertile cases and controls (PTPRN2, RPH3AL). CONCLUSION(S): We found a statistically significant correlation between peripheral blood DNA methylation and male infertility, raising the hope that epigenome-based blood markers can be used for screening male infertility risk. The study also identified new candidates for spermatogenesis and fertility.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Sarkar S, Sujit KM, Singh V, et al. Array-based DNA methylation profiling reveals peripheral blood differential methylation in male infertility. Fertil Steril. 2019. PMID: 31103287. doi:10.1016/j.fertnstert.2019.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。